Plexus Corp. (NASDAQ:PLXS) Given Average Rating of “Hold” by Brokerages

Shares of Plexus Corp. (NASDAQ:PLXSGet Free Report) have been given a consensus rating of “Hold” by the five brokerages that are covering the stock, Marketbeat.com reports. Three research analysts have rated the stock with a hold recommendation and two have assigned a buy recommendation to the company. The average 1 year target price among analysts that have updated their coverage on the stock in the last year is $159.00.

Several equities research analysts have commented on PLXS shares. Wall Street Zen lowered Plexus from a “buy” rating to a “hold” rating in a research report on Saturday, November 22nd. Needham & Company LLC upped their target price on shares of Plexus from $158.00 to $165.00 and gave the stock a “buy” rating in a report on Thursday, October 23rd. Weiss Ratings restated a “hold (c+)” rating on shares of Plexus in a report on Wednesday, October 8th. Sidoti cut Plexus from a “buy” rating to a “neutral” rating and set a $150.00 price objective on the stock. in a report on Friday, October 24th. Finally, Stifel Nicolaus set a $150.00 price target on shares of Plexus in a research note on Friday, October 24th.

Get Our Latest Stock Report on PLXS

Insider Activity at Plexus

In other Plexus news, CFO Patrick John Jermain sold 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, November 11th. The shares were sold at an average price of $143.53, for a total value of $287,060.00. Following the completion of the transaction, the chief financial officer owned 16,961 shares of the company’s stock, valued at $2,434,412.33. This trade represents a 10.55% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at this link. Also, Director Karen Marie Rapp sold 500 shares of the company’s stock in a transaction on Friday, November 28th. The stock was sold at an average price of $143.47, for a total value of $71,735.00. Following the sale, the director directly owned 7,665 shares in the company, valued at $1,099,697.55. This represents a 6.12% decrease in their position. The SEC filing for this sale provides additional information. Insiders sold 13,172 shares of company stock worth $1,883,740 over the last 90 days. 1.76% of the stock is currently owned by corporate insiders.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in the business. Allworth Financial LP raised its position in shares of Plexus by 70.1% during the 3rd quarter. Allworth Financial LP now owns 250 shares of the technology company’s stock worth $36,000 after acquiring an additional 103 shares in the last quarter. Cambria Investment Management L.P. raised its stake in Plexus by 24.8% during the 3rd quarter. Cambria Investment Management L.P. now owns 4,218 shares of the technology company’s stock worth $610,000 after acquiring an additional 837 shares in the last quarter. CIBC Bancorp USA Inc. acquired a new stake in shares of Plexus in the 3rd quarter valued at about $415,000. Captrust Financial Advisors increased its holdings in shares of Plexus by 2.6% in the 3rd quarter. Captrust Financial Advisors now owns 13,238 shares of the technology company’s stock valued at $1,915,000 after acquiring an additional 334 shares during the period. Finally, Morningstar Investment Management LLC acquired a new stake in shares of Plexus during the third quarter worth about $592,000. 94.45% of the stock is owned by institutional investors and hedge funds.

Plexus Price Performance

NASDAQ PLXS opened at $153.29 on Monday. The company has a debt-to-equity ratio of 0.06, a current ratio of 1.58 and a quick ratio of 0.77. Plexus has a 1 year low of $103.43 and a 1 year high of $172.89. The company has a market cap of $4.10 billion, a price-to-earnings ratio of 24.49 and a beta of 0.81. The stock’s fifty day moving average price is $146.11 and its 200 day moving average price is $139.33.

Plexus (NASDAQ:PLXSGet Free Report) last issued its quarterly earnings results on Wednesday, October 22nd. The technology company reported $2.14 earnings per share for the quarter, topping the consensus estimate of $1.84 by $0.30. Plexus had a net margin of 4.29% and a return on equity of 12.77%. The company had revenue of $1.06 billion for the quarter, compared to the consensus estimate of $1.05 billion. During the same quarter in the prior year, the company earned $1.85 EPS. Plexus’s quarterly revenue was up .7% on a year-over-year basis. Plexus has set its Q1 2026 guidance at 1.660-1.810 EPS. As a group, equities research analysts forecast that Plexus will post 5.9 earnings per share for the current year.

Plexus Company Profile

(Get Free Report)

Plexus Corp. (NASDAQ: PLXS) is a global provider of electronics manufacturing services (EMS) and precision engineered electronics solutions. Headquartered in Neenah, Wisconsin, the company partners with original equipment manufacturers across industries such as medical, industrial, aerospace and defense, computing, and communications. Plexus offers a full suite of services that span new product introduction, product lifecycle management, supply chain management, printed circuit board assembly, system integration, and aftermarket support.

Founded in 1979, Plexus has grown from a regional electronics assembler into a multinational organization with manufacturing and engineering centers across North America, Europe, and Asia.

Further Reading

Analyst Recommendations for Plexus (NASDAQ:PLXS)

Receive News & Ratings for Plexus Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Plexus and related companies with MarketBeat.com's FREE daily email newsletter.